Clinical trial reportESMO openPublished
Full enrollment results from cohort 1 of the phase III randomized THOR trial of erdafitinib versus chemotherapy in FGFR-altered advanced urothelial carcinoma
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Mercer County
Publication record
- Type
- Clinical trial report
- Venue
- ESMO open
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Pyrazoles; Quinoxalines; Cohort Studies; Aged; Middle Aged; Female; Male; Receptor, Fibroblast Growth Factor, Type 3; Clinical Trial; Advanced Urothelial Carcinoma; Fgfr Inhibitor
- PubMed ID
- 42815410
- PubMed Central ID
- PMC13654028
- Open access
- Yes, open
- Added to directory
- Source checked